Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Regulatoriskt pressmeddelande

Inhalation Sciences ramps up popular expert webinar series with new release on May 2[nd], 2023

Ladda ner börsmeddelandet

(Stockholm, Sweden, 19 April 2023) Following its highly successful webinar on DissolvIt dissolution studies on March 30[th] - 300 people registered - Inhalation Sciences AB (ISAB) will release two new webinars in 2023. Each will be partnered and co-presented by an industry expert. The next, on May 2[nd] 2023, features in vivo exposures for inhaled medicines with ISAB's PreciseInhale aerosol system showcased by Per Gerde, ISAB's CSO and Founder, and inhalation expert Matt Reed from Coelus Bio. Register for the seminar below.

ISAB is partnering with industry experts in two new webinars in its popular series. The latest webinar, on its unique in vitro module, the DissolvIt method, was extremely well-received, attracting 300 subscribers. It was co-presented by bioanalytic consultant Prof Hermann Mascher, together with ISAB's in vitro specialist and Director of Projects Dr. Maria Malmlöf. Watch the webinar HERE. (https://callboxinc.zoom.us/rec/play/txFzsiw0TM_MlKCIYHpWPVz7yanvF2MAR0KAV1I94VE9o8BOu-A6S6t3vqNiaTFCIuo7wlq9RVvMR-3B.9tTwXYogR0W3IAOh?canPlayFromShare=true&from=share_recording_detail&continueMode=true&componentName=rec-play&originRequestUrl=https%3A%2F%2Fcallboxinc.zoom.us%2Frec%2Fshare%2FHbpyDRgfFQJ1eBK5NJKcExbbdogfJNtMwQLAn98FTgk8BsfjHHnXjjIbDvZql0Z9.QVS-OCRuBXDom8EM)

Webinar #2: May 2[nd] 2023

ISAB will present its next webinar, on in vivo studies, on May 2[nd] 2023 . It will be co-presented by an expert in the field - Matt Reed from Coelus Bio. Matt is a pharmacologist and a board-certified toxicologist with over 25 years' experience in which he has been a part of multiple successful R&D programs that that have transitioned to regulatory approval for small molecules, biologics, oligonucleotides

Register for the May 2[nd] webinar HERE (https://callboxinc.zoom.us/webinar/register/WN_qIrfa4y8QLumAezMXSPCyQ#/registration)

ISAB offers a competitive range of in vivo testing solutions, including its unique intratracheal module. The module uses a catheter connected to PreciseInhale that bypasses the nasal airways, ensuring test substances are retained in the lung and delivering high-precision data of, typically, <10% Standard Deviation.

Webinar #3 - customer partner

ISAB's third expert webinar is expected to be presented later in Fall 2023.

CEO Manoush Masarrat: "These webinars are a superb showcase of our unique expertise and capabilities. I would urge anyone in inhaled pharmaceutical development who is interested in de-risking their drug development early on to register and take part. Our inhalation research services (IRS) are an important key to growth for us, as we share our knowledge and capabilities we build partnerships, increase sales and accelerate our sales cycles."

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.